Related Experiment Video
Updated: Jun 7, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Determinants of platelet catecholamine content: uptake and retention of catecholamines by human platelets in vitro
A J Zweifler1, I Fedorak, M Borondy
1Division of Hypertension, Department of Internal Medicine, The University of Michigan Hospitals, 1500 E. Medical Center Drive, Ann Arbor, Michigan, 48109-0356, USA.
The utility of platelet catecholamine determination in assessing sympathetic nervous system activity depends on the extent to which transient fluctuations of plasma catecholamine concentration can affect platelet catecholamine content. In order to quantitate the relationship between plasma and platelet catecholamine content, the concentrations of norepinephrine, epinephrine and dopamine needed to produce an increase in platelet catecholamines in vitro were determined. The threshold for epinephrine accumulation was 10(-9)M while the thresholds for norepinephrine and dopamine were an order of magnitude higher. The uptake of catecholamines was also found to differ with regard to the time course and the amount of catecholamine accumulated. For example, after 2 h in the presence of equimolar (2 × 10(-8)M) concentrations of catecholamine the platelet content of norepinephrine doubled and epinephrine rose 10-fold and dopamine 20-fold. When platelets that had been loaded with catecholamines were suspended in catecholamine-free buffer, significant amounts of catecholamines were still retained in the platelets after 3 h, but retention of norepinephrine was greater than that of epinephrine. These results indicate the importance of the concentration of the particular catecholamine, duration of exposure of platelets to the catecholamine and the ability of platelets to retain catecholamines, in determining the relationship between plasma and platelet catecholamine content.
The utility of platelet catecholamine determination in assessing sympathetic nervous system activity depends on the extent to which transient fluctuations of plasma catecholamine concentration can affect platelet catecholamine content. In order to quantitate the relationship between plasma and platelet catecholamine content, the concentrations of norepinephrine, epinephrine and dopamine needed to produce an increase in platelet catecholamines in vitro were determined. The threshold for epinephrine accumulation was 10(-9)M while the thresholds for norepinephrine and dopamine were an order of magnitude higher. The uptake of catecholamines was also found to differ with regard to the time course and the amount of catecholamine accumulated. For example, after 2 h in the presence of equimolar (2 × 10(-8)M) concentrations of catecholamine the platelet content of norepinephrine doubled and epinephrine rose 10-fold and dopamine 20-fold. When platelets that had been loaded with catecholamines were suspended in catecholamine-free buffer, significant amounts of catecholamines were still retained in the platelets after 3 h, but retention of norepinephrine was greater than that of epinephrine. These results indicate the importance of the concentration of the particular catecholamine, duration of exposure of platelets to the catecholamine and the ability of platelets to retain catecholamines, in determining the relationship between plasma and platelet catecholamine content.
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Drugs Affecting Neurotransmitter Synthesis
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

